Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice-Reference-Cited by-同舟云学术

Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice

Published:2023-03-13 Issue:5 Volume:20 Page:287-304
ISSN:1759-4774
Container-title:Nature Reviews Clinical Oncology
language:en
Short-container-title:Nat Rev Clin Oncol

Author:

van Hoogstraten Lisa M. C.^ORCID,Vrieling Alina^ORCID,van der Heijden Antoine G.,Kogevinas Manolis^ORCID,Richters Anke^ORCID,Kiemeney Lambertus A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://www.nature.com/articles/s41571-023-00744-3.pdf

Reference192 articles.

1. Alanee, S. et al. Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder. World J. Urol. 37, 107–114 (2019).

2. Cancer Genome Atlas Research Network.Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315–322 (2014).

3. van Rhijn, B. W. G. et al. Prognostic value of the WHO1973 and WHO2004/2016 classification systems for grade in primary Ta/T1 non-muscle-invasive bladder cancer: a multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study. Eur. Urol. Oncol. 4, 182–191 (2021).

4. Cambier, S. et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance Bacillus Calmette-Guérin. Eur. Urol. 69, 60–69 (2016).

5. Oszczudlowski, M. & Dobruch, J. Prediction of progression to muscle-invasive disease in patients with high-risk bladder cancer. Transl. Androl. Urol. 7, 749–751 (2018).

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing and experimental validating a B cell exhaustion-related gene signature to assess prognosis and immunotherapeutic response in bladder cancer;Gene;2024-11

2. Reducing financial toxicity in bladder cancer care;Current Opinion in Urology;2024-09-02

3. Evaluation of miRNA 130a-3P and miRNA 301a-3P in Egyptian patients with urinary bladder carcinoma;Human Gene;2024-09

4. Impact of iron oxide alginate berbamine nanocomposites on the pre-metastatic microenvironment of human bladder cancer cells through ROS-mediated mitochondrial depolarization;Journal of Drug Delivery Science and Technology;2024-09

5. Disulfidptosis and ferroptosis related genes define the immune microenvironment and NUBPL serves as a potential biomarker for predicting prognosis and immunotherapy response in bladder cancer;Heliyon;2024-09